Overview


According to FutureWise analysis the market for Defibrillator is to reach US$ 12,517.2 million in 2022, and is expected to grow at a CAGR of 9.8% over the forecast period of 2023-2031.

Defibrillators are medical equipment that shock or pulse electricity into the heart to restore a regular heartbeat. They prevent or cure an arrhythmia, often known as an irregular, too slow, or too-fast heartbeat. A heart that has unexpectedly stopped beating can also be revived using defibrillators. Defibrillators exist in a range of styles and function in various ways. Automated external defibrillators (AEDs), now common in public areas, can save people experiencing cardiac arrest. In an emergency, even untrained bystanders can use these instruments. Other defibrillators can prevent sudden death when a person is at high risk for developing a life-threatening arrhythmia. These include implanted cardioverter defibrillators (ICDs) placed inside your body through surgery and wearable cardioverter defibrillators (WCDs).

The market for defibrillators will expand gradually due to the rise in the cardiovascular disorders. The significant cause of death and disability worldwide is cardiovascular disease (CVD). Diabetes, hypertension, obesity, dyslipidemia, and other lifestyle illnesses are major risk factors for CVD and are on the rise. The chance of having CVD is significantly correlated with high blood pressure levels. The increasing emphasis on making defibrillators accessible to the general public will also significantly impact the market for defibrillators.

FutureWise Market Research has published a report that provides an insightful analysis of defibrillator market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the defibrillator market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Medtronic
  • St. Jude Medical LLC
  • Boston Scientific Corporation
  • Physio-Control Inc.
  • LivaNova
  • MS Westfalia GmbH
  • Koninklijke Philips N.V.
  • Schiller AG
  • ZOLL Medical Corporation
  • Cardiac Science
  • Nihon Kohden Corporation
  • Defibtech LLC
  • Progetti Srl
  • AMI Italia, Ltd.
  • Biotronik
  • CU Medical Systems
  • Mediana
  • Metsis Medikal
  • Microport
  • Mindray Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Defibrillator Market:

In September 2022- In Chennai, India, Kauvery Hospital established the Restart Heart Foundation. With this organization, more than 100 AEDs were placed at strategic locations throughout Chennai.

Atrial fibrillation, which is distinguished by an irregular and frequently fast heartbeat, can increase the risk of stroke and other heart-related effects in the aged population and in persons with chronic conditions such as high blood pressure, obesity, and heart abnormalities. Atrial fibrillation is the most typical cardiac arrhythmia, according to a report that was released in NCBI 2021. Additionally, the WHO estimates that by 2021, heart attacks and strokes will be responsible for 85% of all cardiovascular deaths. Defibrillators are medical devices that shock the heart with electricity to return it to a normal heartbeat. Arrhythmias are treated or prevented with defibrillators. Defibrillators will therefore be more in demand as heart-related ailments become more prevalent. Moreover, despite advancements in treatment and prevention, sudden cardiac arrest is the cause of about half of all deaths from cardiovascular disease. This is anticipated to encourage market innovation and increase demand for ICDs and external defibrillators. For instance, an ICD is a battery-powered, subcutaneously implanted heart rate monitor. Minuscule cables link a person's heart and the ICD. If the device notices an abnormal cardiac rhythm, it will shock the patient to restore a normal heartbeat. Additionally, it is anticipated that the growing number of products released by different governments and market players will contribute to the market's growth. However, data suggests that operator use errors and mistakes in device care and maintenance are to blame for a major portion of defibrillator failures, even though component problems can account for some defibrillator failures. Additionally, AEDs used in public settings are occasionally vulnerable to failure due to battery, software, and hardware issues. Therapy without defibrillation may be delayed, or fatalities may occur. Numerous defibrillators have been recalled over the years due to technical problems with how the device delivered shocks, electrical problems, and hardware configuration. Defects may lead to poor product performance and patient fatality in the worst situations. Such errors due to defibrillators are expected to hinder market growth.

By Type

  • Implantable Cardioverter Defibrillators (ICDs)
    •     Transvenous Implantable Cardioverter Defibrillators
    •     Subcutaneous Implantable Cardioverter Defibrillators
  • External Defibrillators
    •     Manual & Semi-Automated External Defibrillators
    •     Fully Automated External Defibrillators
    •     Wearable Cardioverter Defibrillators

By End User

  • Hospitals, Clinics, and Cardiac Centers
  • Prehospital Care Settings
  • Public Access Markets
  • Home Care Settings
  • Alternate Care Facilities

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. APAC registered highest share in the market in 2022. This is due to the growing patient population, expanding healthcare infrastructure, and increasing prevalence of heart disorders. Due to the widespread use of defibrillators and supporting policies, the Japanese market is driving regional growth. Additionally based on type; implantable cardioverter defibrillators hold highest market share in 2022. The high prevalence of cardiovascular disorders, the large elderly population in key markets, and the ongoing product developments by major companies are the main factors propelling this segment.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Defibrillators Market By Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Defibrillators Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Defibrillators Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Defibrillators Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Defibrillators Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Implantable Cardioverter Defibrillators (ICDs)
         1.1. Transvenous Implantable Cardioverter Defibrillators
         1.2. Subcutaneous Implantable Cardioverter Defibrillators
        2. External Defibrillators
         2.1. Manual and Semi-Automated External Defibrillators
         2.2. Fully Automated External Defibrillators
         2.3. Wearable Cardioverter Defibrillators

  • 8.   Global Defibrillators Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals, Clinics, and Cardiac Centers
        2. Prehospital Care Settings
        3. Public Access Markets
        4. Home Care Settings
        5. Alternate Care Facilities

  • 9.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe

  • 12.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. St. Jude Medical LLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Physio-Control Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. LivaNova
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MS Westfalia GmbH
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Koninklijke Philips N.V
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Schiller AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. ZOLL Medical Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cardiac Science
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Nihon Kohden Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Defibtech LLC
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Progetti Srl
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. AMI Italia, Ltd.
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        15. Biotronik
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. CU Medical Systems
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Mediana
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Metsis Medikal
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Microport
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Mindray Medical
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 15.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 16.   FutureWise SME key takeaway points for Client
Partner

Our Clients